Search

Author/Creator Lam, Raymond L. H.

1. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Issue 2 (22nd December 2021)

Authors:
Shankar, R. Ravi; Zeitler, Philip; Deeb, Asma; Jalaludin, Muhammad Yazid; Garcia, Raymundo; Newfield, Ron S.; Samoilova, Yulia; Rosario, Carmen A.; Shehadeh, Naim; Saha, Chandan K.; Zhang, Yilong; Zilli, Martina; Scherer, Lynn W.; Lam, Raymond L. H.; Golm, Gregory T.; Engel, Samuel S.; Kaufman, K...
Journal:
Pediatric diabetes
Issue:
Volume 23:Issue 2(2022)
Page Start:
173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study. Issue 12 (16th August 2018)

Authors:
Scott, Russell; Morgan, Jerry; Zimmer, Zachary; Lam, Raymond L. H.; O'Neill, Edward A.; Kaufman, Keith D.; Engel, Samuel S.; Raji, Annaswamy
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 12(2018)
Page Start:
2876
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study. Issue 4 (9th December 2018)

Authors:
Roussel, Ronan; Duran‐García, Santiago; Zhang, Yilong; Shah, Suneri; Darmiento, Carolyn; Shankar, R. Ravi; Golm, Gregory T.; Lam, Raymond L. H.; O'Neill, Edward A.; Gantz, Ira; Kaufman, Keith D.; Engel, Samuel S.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 4(2019)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open‐label clinical trial. Issue 9 (5th June 2018)

Authors:
Home, Philip D.; Lam, Raymond L. H.; Carofano, Wendy L.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rosenstock, Julio; Hollander, Priscilla A.; Gallwitz, Baptist
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 9(2018)
Page Start:
2220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. Issue 2 (20th December 2021)

Authors:
Jalaludin, Muhammad Yazid; Deeb, Asma; Zeitler, Philip; Garcia, Raymundo; Newfield, Ron S.; Samoilova, Yulia; Rosario, Carmen A.; Shehadeh, Naim; Saha, Chandan K.; Zhang, Yilong; Zilli, Martina; Scherer, Lynn W.; Lam, Raymond L. H.; Golm, Gregory T.; Engel, Samuel S.; Kaufman, Keith D.; Shankar, ...
Journal:
Pediatric diabetes
Issue:
Volume 23:Issue 2(2022)
Page Start:
183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗